Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hadir M. Maher, Afnan E. Abdelrahman, Nourah Z. Alzoman & Haya I. Aljohar. (2019) Stability-indicating capillary electrophoresis method for the simultaneous determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceutical tablets. Journal of Liquid Chromatography & Related Technologies 42:5-6, pages 161-171.
Read now
Read now
Articles from other publishers (24)
Md Saddam Hossain, Sadia Jahan, Sad Al Rezwan Rahman, Mashiur Rahman, Diponkor Kumar, Susmita Paul & Joy Chandra Rajbangshi. (2023) Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities. Heliyon 9:3, pages e14259.
Crossref
Crossref
Olga Y. Rybina, Alexander V. Symonenko & Elena G. Pasyukova. (2023) Compound combinations targeting longevity: Challenges and perspectives. Ageing Research Reviews 85, pages 101851.
Crossref
Crossref
Olusola Olusola Elekofehinti. (2023) Computer-aided identification of bioactive compounds from Gongronema latifolium leaf with therapeutic potential against GSK3β, PTB1B and SGLT2. Informatics in Medicine Unlocked 38, pages 101202.
Crossref
Crossref
Ali K. Abu-Alfa, Paola J. Atallah, Sami T. Azar, Elissar C. Dagher, Akram S. Echtay, Mireille A. El-Amm, Habib G. Hazkial, Roland Y. Kassab, Rita C. Medlej & Malek A. Mohamad. (2022) Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications. Diabetes Therapy 14:1, pages 11-28.
Crossref
Crossref
Olusola Olalekan Elekofehinti, Esther Opeyemi Ariyo, Opeyemi Iwaloye & Tajudeen O Obafemi. (2022) Co-administration of metformin and gallic acid modulates JAK/STAT signaling pathway and glutathione metabolism in fructose-fed streptozotocin diabetic Rats. Phytomedicine Plus 2:1, pages 100181.
Crossref
Crossref
Amira F. El-Yazbi. (2021) Green methods for the simultaneous analysis of pharmaceutical mixtures present in disparate concentration ranges: Application to antidiabetic mixtures. Microchemical Journal 164, pages 106073.
Crossref
Crossref
Amit Kaushal, Sandeep Arora, Neelam Sharma & Sukhbir Singh. (2021) Development of Bilayer Tablet Containing Saxagliptin Immediate Release and Metformin Sustained Release Using Quality by Design Approach. Current Drug Therapy 16:2, pages 184-203.
Crossref
Crossref
Abdallah Y. Naser, Zahra Alsairafi, Hassan Alwafi, Fawaz Mohammad Turkistani, Nedaa Saud Bokhari, Badi Alenazi, Eman Zmaily Dahmash & Hamad S. Alyami. (2020) The perspectives of physicians regarding antidiabetic therapy de‐intensification and factors affecting their treatment choices—A cross‐sectional study. International Journal of Clinical Practice 75:1.
Crossref
Crossref
Pascale Fouqueray, Sandrine Perrimond-Dauchy & Sébastien Bolze. (2020) Imeglimin Does Not Induce Clinically Relevant Pharmacokinetic Interactions When Combined with Either Metformin or Sitagliptin in Healthy Subjects. Clinical Pharmacokinetics 59:10, pages 1261-1271.
Crossref
Crossref
Christopher R. Simpson, Helena M. Kelly & Ciara M. Murphy. (2020) Synergistic use of biomaterials and licensed therapeutics to manipulate bone remodelling and promote non-union fracture repair. Advanced Drug Delivery Reviews 160, pages 212-233.
Crossref
Crossref
Kohei Kaku, Koichi Kisanuki, Mari Shibata & Takashi Oohira. (2019) Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus. Drug Safety 42:11, pages 1311-1327.
Crossref
Crossref
Sho-ichi Yamagishi, Ami Sotokawauchi & Takanori Matsui. (2019) Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation. Mini-Reviews in Medicinal Chemistry 19:13, pages 1040-1048.
Crossref
Crossref
Pradipta Das, Michael D. Delost, Munaum H. Qureshi, David T. Smith & Jon T. Njardarson. (2018) A Survey of the Structures of US FDA Approved Combination Drugs. Journal of Medicinal Chemistry 62:9, pages 4265-4311.
Crossref
Crossref
N. A. PetuninaA. L. Terekhova. (2019) Reliable choice in therapy of type 2 diabetes mellitus: focus on alogliptin. Medical Council:21, pages 138-145.
Crossref
Crossref
S. Halimi. (2018) Diabète de type 2 : observance thérapeutique aux nouveaux antidiabétiques. Médecine des Maladies Métaboliques 12:6, pages 487-495.
Crossref
Crossref
Kota Imai, Hiroki Murayama & Takahisa Hirose. (2018) Choice of Treatment Regimen as Add-On to Insulin in Japanese Patients with Type 2 Diabetes Mellitus: Physicians’ Perspective in a Real-World Setting, Insight from a Web Survey. Diabetes Therapy 9:5, pages 1869-1881.
Crossref
Crossref
George Dailey, Timothy Reid, John White, Jason Chao, Fang L. Zhou, Sachin Paranjape & Paulos Berhanu. (2018) Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL. Endocrinology, Diabetes & Metabolism 1:4, pages e00035.
Crossref
Crossref
Hiroki Murayama, Kota Imai & Masato Odawara. (2018) Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey. Diabetes Therapy 9:3, pages 1185-1199.
Crossref
Crossref
Neil Skolnik, Debbie Hinnen, Yan Kiriakov, Melissa L. Magwire & John R. WhiteJr.Jr.. (2018) Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know. Clinical Diabetes 36:2, pages 174-182.
Crossref
Crossref
Ying Peng, Qingqing Chang, Na Yang, Shiyin Gu, Yi Zhou, Lifang Yin, Jiye Aa, Guangji Wang & Jianguo Sun. (2018) Quantitative determination of metformin, saxagliptin and 5-hydroxy saxagliptin simultaneously by hydrophilic interaction liquid chromatography - electrospray ionization mass spectrometry and its application to a bioequivalence study with a single-pill combination in human. Journal of Chromatography B 1081-1082, pages 109-117.
Crossref
Crossref
Eugenio Cersosimo, Eric L. Johnson, Christina Chovanes & Neil Skolnik. (2018) Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach. Diabetes, Obesity and Metabolism 20:3, pages 497-507.
Crossref
Crossref
Ellen M. Janssen, A. Brett Hauber & John F.P. Bridges. (2018) Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments. Value in Health 21:1, pages 59-68.
Crossref
Crossref
Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee & Byung-Wan Lee. (2017) Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study). Journal of Diabetes Research 2017, pages 1-8.
Crossref
Crossref
Melissa Murfin. (2017) Special Considerations in Choosing Diabetes Therapy. Physician Assistant Clinics 2:1, pages 39-52.
Crossref
Crossref